Balyasny Asset Management »

Acumen Pharmaceuticals shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $32k 12k 2.67
2024-03-31 $259k 64k 4.05
2023-12-31 $79k 21k 3.84
2023-06-30 $145k 30k 4.81

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Select Sector Spdr Tr St Str Finl Etf Call Option (XLF)
Meta Platforms Cl A Call Option (META)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Warner Bros Discovery Com Ser A Call Option (WBD)
Space Exploration Techn Corp Class A Com Stk Call Option (SPCX)
Microsoft Corporation Call Option (MSFT)
Tesla Motors Call Option (TSLA)

View all positions for Balyasny Asset Management

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Sands Capital Ventures
BlackRock
Alyeska Investment Group
Franklin Resources
ADAR1 Capital Management
Vanguard Capital Management
Knollwood Investment Advisory
Geode Capital Management
Ikarian Capital
Hudson Bay Capital Management
Pathstone Holdings
Renaissance Technologies
Two Sigma Investments
Northern Trust

View all funds holding Acumen Pharmaceuticals